Wingspan Tech Partners with Japan-based ISID
Wingspan Technology announces a partnership with Information Services International-Dentsu, Ltd. (ISID) in support of the Wingspan Life Sciences Solutions platform. ISID will bring Wingspan’s cloud solutions - including Wingspan eTMF, SiteZone site document exchange portal, and eREG Regulatory document EDMS built to support eCTD submissions - to the Japanese market. ISID, a systems integrator based out of Tokyo, Japan, works with many pharmaceutical and life science companies. Japan’s pharmaceutical industry has experienced major growth in the past decade. In order to better support the strengthening Japanese pharmaceutical industry, ISID will provide a variety of services to support Japanese clients using Wingspan Life Sciences Solutions, including project management, business analysis, training, migration support, and systems integrations. “ISID has a history of providing top level technology consulting services in Japan and the surrounding markets,” said Wingspan President Troy Deck. “We are excited to partner with such a well-established organization as we explore new opportunities in the Asia-Pacific regions.” In 2012, the Japanese government released a 5-year plan for clinical research and clinical trial activation to improve the cost, speed, and quality of clinical trials. This plan included a national movement toward eTMF systems. "Wingspan provides the most advanced eTMF system and has many years of experience deploying into many global pharmaceutical companies,” said Kenji Ichikawa, Senior Managing Director, Member of the Board. “It is a great honor to work with Wingspan and deliver their complete, consistent and compliant system for our market." Wingspan, now in its twentieth year in business, released its first eTMF in 2009 and was one of the first companies to offer a cloud-based eTMF system. About Wingspan Technology, Inc.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025